Clinical Trials
68
Active:4
Completed:6
Trial Phases
5 Phases
Phase 1:28
Phase 2:23
Phase 3:14
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (67 trials with phase data)• Click on a phase to view related trials
Phase 1
28 (41.8%)Phase 2
23 (34.3%)Phase 3
14 (20.9%)Not Applicable
1 (1.5%)Phase 4
1 (1.5%)Phase I/II Study of SCTB39-1 in Advanced Solid Tumours
Not Applicable
Recruiting
- Conditions
- Advanced Malignant Solid Tumor
- Interventions
- Drug: SCTB39-1
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 110
- Registration Number
- NCT07050641
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Science, Beijing, China
A Study of SCTB35 in Patients with Systemic Lupus Erythematosus
Phase 1
Recruiting
- Conditions
- System Lupus Erythematosus
- Interventions
- Biological: SCTB35 injection
- First Posted Date
- 2025-02-21
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 168
- Registration Number
- NCT06841042
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China
🇨🇳Xuanwu Hospital, Capital Medical University, Beijing, China
🇨🇳Jilin Provincial People's Hospital, Changchun, China
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster Vaccine
Phase 1
Not yet recruiting
- Conditions
- Herpes Zoster
- Interventions
- Biological: Recombinant Herpes Zoster Vaccine (SCTV04C) Low-DoseBiological: Ganwei®Biological: Recombinant Herpes Zoster Vaccine (SCTV04C) High-DoseBiological: Shingrix®
- First Posted Date
- 2025-01-30
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 540
- Registration Number
- NCT06801509
- Locations
- 🇨🇳
Dazhu CDC, Dazhou, Sichuan, China
A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 99
- Registration Number
- NCT06774664
- Locations
- 🇨🇳
The First Affiliated Hospital of Baotou Medical College, Baotou, China
🇨🇳Beijing Tsinghua Changgung Hospital, Beijing, China
🇨🇳Peking University First Hospital, Beijing, China
A Study of SCTT11 in Healthy Participants and Participants with Thyroid Eye Disease.
- First Posted Date
- 2025-01-10
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT06769984
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next
News
No news found